Sandeep Tandon of Quant Mutual Fund believes India is decoupling from developed economies, particularly within the Asia-centric emerging market. He highlights the pharma sector as a key beneficiary in the current economic climate, dismissing concerns about significant US tariffs on Indian generics. Tandon advocates investing in pharma funds, viewing it as a straightforward and promising strategy.
Muted Q4, weak forecast cast a shadow on HCLTech
HCLTech’s revenue growth guidance for FY27 is significantly lower than the actual FY26 growth, implying the effect of growing dependence of clients on operating efficiencies
April 22, 2026